|
| Issue Date | Title | Author(s) |
| Sep-2013 | 6-Aryl and heterocycle quinazoline derivatives as potent EGFR inhibitors with improved activity toward gefitinib-sensitive and -resistant tumor cell lines | Hamed, Mostafa M; Abou El Ella, Dalal ; Keeton, Adam B; Piazza, Gary A; Abadi, Ashraf H; Hartmann, Rolf W; Engel, Matthias |
| 21-Oct-2024 | Advancements in current one-size-fits-all therapies compared to future treatment innovations for better improved chemotherapeutic outcomes: a step-toward personalized medicine | Basalious, Emad B; Kabel, Ahmed M; Nossier, Eman S; Abadi, Ashraf H; Nasr, Maha; Prof. Hamdy, Nadia M. ; El-Sisi, Mona G |
| 15-Aug-2009 | Design, synthesis and biological evaluation of novel pyridine derivatives as anticancer agents and phosphodiesterase 3 inhibitors | Abadi, Ashraf H; Ibrahim, Tamer M; Khaled A M Abouzid ; Lehmann, Jochen; Tinsley, Heather N; Gary, Bernard D; Piazza, Gary A |
| 21-Oct-2016 | Discovery of novel Tetrahydrobenzo[b]thiophene and pyrrole based scaffolds as potent and selective CB2 receptor ligands: The structural elements controlling binding affinity, selectivity and functionality | Osman, Noha A; Ligresti, Alessia; Klein, Christian D; Allarà, Marco; Rabbito, Alessandro; Di Marzo, Vincenzo; Abouzid, Khaled ; Abadi, Ashraf H |
| Jun-2013 | Synthesis and binding study of certain 6-arylalkanamides as molecular probes for cannabinoid receptor subtypes | Taher, Azza T; Kadry, Hanan H; Allarà, Marco; Di Marzo, Vincenzo; Abadi, Ashraf H; Abouzid, Khaled |
| 15-Dec-2010 | Synthesis, binding studies and molecular modeling of novel cannabinoid receptor ligands | Osman, Noha A; Mahmoud, Amr H; Allarà, Marco; Niess, Raimund; Khaled A M Abouzid ; Di Marzo, Vincenzo; Abadi, Ashraf H |
